Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Cash from Financing Activities (2021 - 2026)

bioAffinity Technologies has reported Cash from Financing Activities over the past 5 years, most recently at -$118513.0 for Q1 2026.

  • Quarterly Cash from Financing Activities fell 111.48% to -$118513.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $13.6 million through Mar 2026, up 192.71% year-over-year, with the annual reading at $14.7 million for FY2025, 161.82% up from the prior year.
  • Cash from Financing Activities was -$118513.0 for Q1 2026 at bioAffinity Technologies, down from $1.3 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $15.0 million in Q3 2022 and troughed at -$563556.0 in Q4 2022.
  • The 5-year median for Cash from Financing Activities is $301363.0 (2022), against an average of $2.0 million.
  • Year-over-year, Cash from Financing Activities crashed 127.65% in 2023 and then skyrocketed 3412.08% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$563556.0 in 2022, then soared by 84.95% to -$84805.0 in 2023, then skyrocketed by 2488.86% to $2.0 million in 2024, then tumbled by 33.85% to $1.3 million in 2025, then tumbled by 108.84% to -$118513.0 in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Cash from Financing Activities are -$118513.0 (Q1 2026), $1.3 million (Q4 2025), and $9.3 million (Q3 2025).